Increased Plasma Heparanase Activity in COVID-19 Patients

Authors :: Buijsers, B.
Yanginlar, C.
Nooijer, A.H. de
Grondman, I.
Maciej-Hulme, M.L.
Jonkman, W.I.
Janssen, N.A.F.
Rother, N
Graaf, M.J.J. de
Pickkers, P.
Kox, M.
Joosten, L.A.B.
Nijenhuis, T.
Netea, M.G.
Hilbrands, L.B.
Veerdonk, F.L. van de
Duivenvoorden, R.
Mast, Q. de
Vlag, J. van der
Buijsers, B.
Yanginlar, C.
Nooijer, A.H. de
Grondman, I.
Maciej-Hulme, M.L.
Jonkman, W.I.
Janssen, N.A.F.
Rother, N
Graaf, M.J.J. de
Pickkers, P.
Kox, M.
Joosten, L.A.B.
Nijenhuis, T.
Netea, M.G.
Hilbrands, L.B.
Veerdonk, F.L. van de
Duivenvoorden, R.
Mast, Q. de
Vlag, J. van der
Source :: Frontiers in Immunology; 1664-3224; vol. 11; 575047; ~Frontiers in Immunology~~~~~1664-3224~~11~~575047
Publication Year :: 2020
Abstract: Contains fulltext : 226238.pdf (publisher's version ) (Open Access)

Database :: OAIster
Journal :: Frontiers in Immunology; 1664-3224; vol. 11; 575047; ~Frontiers in Immunology~~~~~1664-3224~~11~~575047
Publication Type :: Electronic Resource
Accession number :: edsoai.on1284121987
Document Type :: Electronic Resource